Poly(ADP-ribose) polymerase (PARP) inhibitors in cardiovascular, and cerebrovascular diseases: mechanisms, current trends and challenge for clinical translation

聚（ADP-核糖）聚合酶（PARP）抑制剂在心血管和脑血管疾病中的应用：机制、当前趋势及临床转化挑战